Novartis has produced a new drug named ENTRESTO. It is a combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker, indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction. They list all the preliminary side effects.
After its release they found it can cause macular degeneration and Altzheimer disease.
If you already have the preliminary factors for macular degeneration, such as hereditaty predisposition, smoking, over-65, poor diet, slow adjustment to darkness, etc., discuss with your doctor if he prescribes Entresto.
For more info: